Adventis Group PLC
13 March 2007
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to
which voting rights are attached
ADVENTIS GROUP PLC
2. Reason for the notification (please tick the appropriate box or boxes)
An acquisition or disposal of voting rights ( )
An acquisition or disposal of financial instruments which may ( )
result in the acquisition of shares already issued to which
voting rights are attached
An event changing the breakdown of voting rights ( )
Other ( X)
(specify):
3. Full name of person(s) subject to the notification obligation:
UBS Investment Bank
4. Full name of shareholder(s) (if different from 3.)
n/a
5. Date of the transaction (and date on which the threshold is crossed
or reached if different):
8 March 2007 (see note 13)
6. Date on which issuer notified:
9 March 2007
7. Threshold(s) that is/are crossed or reached:
Below 3%
8. Notified details:
A. Voting rights attached to shares
Class/type of shares (if possible using the GB00B01G6R56
ISIN code)
Situation previous Resulting situation after the triggering transaction
to the triggering
transaction
Number of Number of Voting Number of Number of Voting % of voting
Shares Rights Shares Rights rights
Direct Direct Indirect Direct Indirect
1,377,632 1,377,632 Non- Non- Below
notifiable notifiable 3%
B. Financial Instruments
Resulting situation after the triggering transaction
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that may rights
instrument Period/Date be acquired if
the instrument is
exercised/
converted
Total (A+B)
Number of voting rights % of voting rights
Non-notifiable Below 3%
9. Chain of controlled undertakings through which the voting rights and/
or the financial instruments are effectively held, if applicable:
Proxy Voting:
10. Name of the proxy holder: -
11. Number of voting rights proxy -
holder will cease to hold:
12. Date on which proxy holder -
will cease to hold voting
rights:
13. Additional information: This disclosure has been made to fulfil
the below FSA requirement:
The Transparency Directive states that
where a major shareholder has not been
required (because of an acquisition or
disposal of voting rights or due to a
change in the total of voting rights in
issue) to make an announcement to the
issuer prior to 20 March 2007, then we
must do so by that date in any event.
In addition to this, please note that
UBS are no longer required to include
prime brokerage holdings in the
disclosures under DTR5 under the
Transparency Directive.
14: Contact name: Angela Huff, Associate Director, UBS AC
15. Contact telephone number: 020 7568 4981
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.